2-Cyano-N-(6-(3,4-dichlorophenyl)pyridin-2-yl)acetamide

ID: ALA4538423

PubChem CID: 155548991

Max Phase: Preclinical

Molecular Formula: C14H9Cl2N3O

Molecular Weight: 306.15

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  N#CCC(=O)Nc1cccc(-c2ccc(Cl)c(Cl)c2)n1

Standard InChI:  InChI=1S/C14H9Cl2N3O/c15-10-5-4-9(8-11(10)16)12-2-1-3-13(18-12)19-14(20)6-7-17/h1-5,8H,6H2,(H,18,19,20)

Standard InChI Key:  FWBFSRMVDRCHSZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   26.0331  -17.8874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0320  -18.7069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7400  -19.1159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.4497  -18.7064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4469  -17.8838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7383  -17.4785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1545  -19.1132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1545  -19.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8620  -20.3389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5700  -19.9291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5661  -19.1077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8580  -18.7040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3240  -19.1149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.6166  -18.7058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9085  -19.1138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6172  -17.8886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.2012  -18.7047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4957  -18.2967    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2717  -18.6955    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   30.2789  -20.3356    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4  7  1  0
  2 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 17 18  3  0
 11 19  1  0
 10 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4538423

    ---

Associated Targets(Human)

ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.15Molecular Weight (Monoisotopic): 305.0123AlogP: 3.91#Rotatable Bonds: 3
Polar Surface Area: 65.78Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.25CX Basic pKa: 2.19CX LogP: 3.78CX LogD: 3.78
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.93Np Likeness Score: -2.00

References

1. Simpson GL, Bertrand SM, Borthwick JA, Campobasso N, Chabanet J, Chen S, Coggins J, Cottom J, Christensen SB, Dawson HC, Evans HL, Hobbs AN, Hong X, Mangatt B, Munoz-Muriedas J, Oliff A, Qin D, Scott-Stevens P, Ward P, Washio Y, Yang J, Young RJ..  (2019)  Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS Methodologies.,  62  (4): [PMID:30689376] [10.1021/acs.jmedchem.8b01872]

Source